Is either KRAS or BRAF a potentially targeted site to treat patients with ovarian clear cell carcinoma?

Benzer Materyaller

• High frequency of BRAF mutations in primary mucinous ovarian carcinoma of Taiwanese patients
  Yazar:: Wan-Ru Chao, ve diğerleri
  Baskı/Yayın Bilgisi: (2021-11-01)
• The status of KRAS mutations in primary ovarian clear cell carcinoma: An analysis of 17 Taiwanese patients
  Yazar:: Pi-Chieh Wang, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-03-01)
• KRAS and BRAF Mutations as Prognosis Factors in Breast Cancer
  Yazar:: Ngo Pambe CJ, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-01-01)
• Molecular Pattern and Clinical Implications of KRAS/NRAS and BRAF Mutations in Colorectal Cancer
  Yazar:: İvo Gökmen, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-09-01)
• ANALYSIS OF MUTATIONS IN KRAS AND BRAF GENES IN COLORECTAL CANCER IN RUSSIAN PATIENTS
  Yazar:: E. E. Pisareva, ve diğerleri
  Baskı/Yayın Bilgisi: (2016-07-01)